A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.

MLA

Luterbach, Courtney L., et al. “A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections.” Antimicrobial Agents and Chemotherapy, vol. 66, no. 10, Oct. 2022, p. e0059122. EBSCOhost, https://doi.org/10.1128/aac.00591-22.

APA

Luterbach, C. L., Qiu, H., Hanafin, P. O., Sharma, R., Piscitelli, J., Lin, F.-C., Ilomaki, J., Cober, E., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., Kaye, K. S., Nation, R. L., Bonomo, R. A., Landersdorfer, C. B., van Duin, D., & Rao, G. G. (2022). A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy, 66(10), e0059122. https://doi.org/10.1128/aac.00591-22

Chicago

Luterbach, Courtney L, Hongqiang Qiu, Patrick O Hanafin, Rajnikant Sharma, Joseph Piscitelli, Feng-Chang Lin, Jenni Ilomaki, et al. 2022. “A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections.” Antimicrobial Agents and Chemotherapy 66 (10): e0059122. doi:10.1128/aac.00591-22.